Publicacións nas que colabora con MARCOS GARCIA FUENTES (22)

2020

  1. Extracellular matrix mechanics regulate transfection and SOX9-directed differentiation of mesenchymal stem cells

    Acta Biomaterialia, Vol. 110, pp. 153-163

  2. mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering

    Biomaterials, Vol. 247

2019

  1. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells

    Journal of Controlled Release, Vol. 295, pp. 60-73

2016

  1. Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer

    Journal of Controlled Release, Vol. 238, pp. 263-271

  2. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size

    International Journal of Pharmaceutics, Vol. 509, Núm. 1-2, pp. 107-117

2015

  1. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative

    International Journal of Pharmaceutics, Vol. 483, Núm. 1-2, pp. 212-219

  2. HOW REGENERATIVE MEDICINE CAN BENEFIT FROM NUCLEIC ACIDS DELIVERY NANOCARRIERS?

    POLYMERS IN REGENERATIVE MEDICINE: BIOMEDICAL APPLICATIONS FROM NANO- TO MACRO-STRUCTURES (BLACKWELL SCIENCE PUBL), pp. 285-336

2014

  1. Nano-oncologicals: new targeting and delivery approaches

    Springer Suiza

  2. PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties

    Current Topics in Medicinal Chemistry, Vol. 14, Núm. 9, pp. 1115-1123

  3. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 87, Núm. 1, pp. 47-54

  4. Polysaccharide-Based Nanocarriers for Drug Delivery

    Frontiers in Nanobiomedical Research, pp. 235-277

2013

  1. A new potential nano-oncological therapy based on polyamino acid nanocapsules

    Journal of Controlled Release, Vol. 169, Núm. 1-2, pp. 10-16

  2. Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles

    International Journal of Pharmaceutics, Vol. 447, Núm. 1-2, pp. 115-123

2012

  1. Chitosan-based drug nanocarriers: Where do we stand?

    Journal of Controlled Release, Vol. 161, Núm. 2, pp. 496-504

2010

  1. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 75, Núm. 1, pp. 26-32

  2. Chitosan-coated lipid nanocarriers for therapeutic applications

    Journal of Drug Delivery Science and Technology, Vol. 20, Núm. 4, pp. 259-265

  3. Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB

    Drug Delivery, Vol. 17, Núm. 8, pp. 596-604

  4. Nanoparticles based on PLGA: Poloxamer blends for the delivery of proangiogenic growth factors

    Molecular Pharmaceutics, Vol. 7, Núm. 5, pp. 1724-1733

  5. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors

    European Journal of Pharmaceutical Sciences, Vol. 41, Núm. 5, pp. 644-649

2008

  1. PEG-COATED NANOEMULSIONS, A CARRIER OF PHARMACEUTICAL INTEREST FOR THE DELIVERY OF ANTITUMOURAL DRUGS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY